Publications by authors named "Jeffrey Moses"

Background: Calcified nodules (CNs) remain a major challenge in percutaneous coronary intervention (PCI). We sought to compare procedural and clinical outcomes after orbital atherectomy (OA) versus intravascular lithotripsy (IVL)-facilitated PCI in patients with CNs.

Methods: We identified patients with optical coherence tomography (OCT)-defined CNs who underwent PCI with either OA or IVL between 2012 and 2022 and had both pre- and post-PCI OCT images available.

View Article and Find Full Text PDF

Background: Patients with coronary in-stent restenosis (ISR) within multiple layers of stent pose a specific clinical challenge because of higher rates of recurrent restenosis as well as a desire to avoid an additional layer of stent. Drug-coated balloons (DCBs) provide an alternative antiproliferative therapeutic option for multilayer ISR.

Objectives: We evaluated the efficacy and safety of a low-dose paclitaxel-coated vs uncoated balloon among patients with multilayer or single-layer ISR in the AGENT IDE (A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis) trial.

View Article and Find Full Text PDF

Background: Coronary bifurcation lesions (CBL) are associated with lower procedural success, worse postprocedural outcomes, and greater unplanned repeat revascularization. We sought to better understand the impact of Impella support in patients undergoing percutaneous coronary intervention (PCI) of CBLs.

Methods: We used data from the cVAD PROTECT III study (NCT04136392), an FDA-audited, single-arm study of patients undergoing high-risk PCI with Impella support, to examine the outcomes of patients undergoing PCI of CBLs.

View Article and Find Full Text PDF

Background: Coronary stenting alters vessel dynamics, displacing hinge movement closer to stent edges. We aimed to investigate whether calcified nodules (CNs) are more frequent at stent edges associated with calcium.

Methods: In vessels with previously implanted stents evaluated by optical coherence tomography, 4 different calcified lesions were studied: stent-edge calcified lesions with or without a CN, and unstented native calcified lesions with or without a CN.

View Article and Find Full Text PDF

Background: Chronic stent recoil can vary according to both stent materials and designs.

Objectives: The authors sought to use serial optical coherence tomography (OCT) to investigate the incidence of chronic stent recoil and its impact on target lesion revascularization (TLR) in second- or newer-generation drug-eluting stent implantation.

Methods: Patients undergoing clinically indicated serial OCT studies (baseline and either at TLR or after more than 6-month follow-up) were studied.

View Article and Find Full Text PDF

Intravascular imaging (IVI), including intravascular ultrasound and optical coherence tomography, play a crucial role in guiding percutaneous coronary intervention by providing detailed visualization of coronary anatomy and plaque morphology. Despite substantial evidence supporting IVI use, its adoption in clinical practice remains limited for multiple reasons including limited operator experience and a lack of confidence in image interpretation. The emergence of artificial intelligence presents a promising solution to these challenges by enhancing procedural efficiency and precision, thereby potentially increasing both IVI adoption and procedural optimization.

View Article and Find Full Text PDF

Background: Severe calcification is the morphology most strongly associated with stent underexpansion.

Objectives: The aim of this study was to revise an optical coherence tomography (OCT)-derived calcium score to predict stent underexpansion in severely calcified lesions (angle >270°) using a point-based system.

Methods: A retrospective observational study was conducted in which 250 de novo lesions undergoing OCT-guided stenting, with angiographically visible calcium and optical coherence tomographic maximum superficial calcium angle >270°, not subjected to atherectomy or specialty balloon treatment before stent implantation, were randomly divided into derivation (n = 167) and validation (n = 83) cohorts.

View Article and Find Full Text PDF

Since its inception, percutaneous coronary intervention (PCI) has relied upon vessel opacification with iodinated contrast to plan, guide, and assess the results of the procedure. Yet revisiting this fundamental concept is important in contemporary PCI practice, especially in patients with high-risk clinical or anatomical profiles. In addition to decreasing the probability of acute kidney injury during PCI, limiting the volume of iodinated contrast allows the operator to perform more thorough interventions by relying on intracoronary imaging and physiology, ultimately contributing to more complete revascularization and improving the efficacy and durability of the intervention.

View Article and Find Full Text PDF

Background: This retrospective study addresses the role of operator and fluoroscopy equipment in reducing patient radiation exposure in the Cath lab.

Methods: Data from 99,400 procedures performed in our institution between 2007 and 2019 were reviewed. Dosimetric parameters included reference point air kerma (K), Kerma Area Product (P), fluoroscopic time, and contrast volume.

View Article and Find Full Text PDF

Coronary artery disease (CAD) is the leading cause of mortality among patients with chronic kidney disease (CKD), presenting unique challenges in diagnosis and management. Advanced CKD patients often present with atypical symptoms, and conventional diagnostic and interventional approaches carry risks, including contrast-induced nephropathy and the potential need for renal replacement therapy. These risks have led to the phenomenon of "renalism," where necessary procedures may be deferred due to concerns over renal injury.

View Article and Find Full Text PDF
Article Synopsis
  • Calcified nodules (CNs) are high-risk lesions that can emerge from untreated calcified lesions, leading to serious health issues like cardiac death and myocardial infarction.
  • A study with 372 patients tracked the development of new CNs over approximately 1.5 years, finding that 7% of lesions showed new CNs at follow-up.
  • Factors like the presence of residual lipid, larger calcified volume, increased motion during heart cycles, and longer time since initial imaging were linked to the formation of new CNs and were associated with worse clinical outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Photon-counting detector-computed tomography (PCD-CT) technology offers better spatial resolution and may improve diagnostic performance for obstructive coronary artery disease (CAD) compared to traditional energy-integrating detector computed tomography (EID-CT).
  • A study of 7,833 patients showed that those who had PCD-CT were less likely to be referred for invasive coronary angiography (ICA) and had higher rates of revascularization when referred.
  • PCD-CT demonstrated significantly better specificity, positive predictive value, and diagnostic accuracy at the vessel level compared to EID-CT, with similar sensitivity and negative predictive value results.
View Article and Find Full Text PDF
Article Synopsis
  • In a study analyzing patients during high-risk percutaneous coronary intervention (HR-PCI), nearly half (49%) experienced loss of pulse pressure (LOPP), defined as a mean pulse pressure below 20 mm Hg for 5 seconds or more.
  • Patients with LOPP demonstrated significantly lower baseline systolic and mean arterial blood pressures and a higher heart rate compared to those without LOPP.
  • The occurrence of LOPP was linked to a higher incidence of serious complications including major adverse cardiac events, acute kidney injury, and death within 90 days, with low systolic blood pressure and cardiomyopathy identified as strong predictors of LOPP.
View Article and Find Full Text PDF

Background: Mitral valve regurgitation (MR) is associated with worse outcomes in patients undergoing percutaneous coronary intervention (PCI). We sought to evaluate outcomes of Impella-supported high-risk PCI (HRPCI) patients according to MR severity.

Methods: Patients from the PROTECT III study undergoing Impella-supported HRPCI were stratified into 4 groups according to MR severity: No or trace MR, mild MR, moderate MR, and severe MR.

View Article and Find Full Text PDF

Background: Patients with complex coronary artery disease, as defined by high SYNTAX scores, undergoing percutaneous coronary intervention (PCI) have poorer outcomes when compared with patients with lower SYNTAX I scores. This study aimed to assess if mechanical circulatory support using Impella mitigates the effect of the SYNTAX I score on outcomes after high-risk percutaneous coronary intervention (HRPCI).

Methods: Using data from the PROTECT III study, patients undergoing Impella-assisted HRPCI between March 2017 and March 2020 were divided into 3 cohorts based on SYNTAX I score-low (≤22), intermediate (23-32), and high (≥33).

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the connection between acute brain injuries detected by diffusion-weighted MRI and stroke outcomes in patients who undergo transcatheter aortic valve replacement (TAVR).
  • A total of 495 patients were analyzed, revealing that 85% experienced brain injuries, with a significant link between the total lesion volume and the occurrence of clinical strokes.
  • The findings suggest that measuring the extent of brain injury could be important for predicting stroke risk and recovery in TAVR patients, indicating potential for enhancing stroke prevention strategies.
View Article and Find Full Text PDF
Article Synopsis
  • * The DISCOVER INOCA registry aims to enroll 500 patients to study the prevalence of different INOCA phenotypes and their relationship with atherosclerosis over a follow-up period of five years, assessing both short-term and long-term health outcomes.
  • * This study is the first to prospectively combine anatomical and physiological data to better understand INOCA and its effects on long-term cardiovascular health, potentially improving diagnosis and treatment strategies.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the use of off-label peripheral drug-coated balloons (P-DCB) for treating coronary in-stent restenosis (ISR) in patients, as dedicated drug-coated balloons are not available in the U.S.
  • Data from 31 patients treated at a high-volume center showed that a significant percentage had recurrent ISR and high-grade symptoms, with most lesions found in native coronary arteries.
  • Follow-up indicated that while no post-procedural heart attacks occurred, there was a notable recurrence rate of ISR, with only 44.7% of patients free from further issues at the time of follow-up.
View Article and Find Full Text PDF

Background: Although use of sirolimus-based analogs has shown superiority over paclitaxel in drug-eluting stents, the relative efficacy of these two agents released from drug-coated balloons (DCB) is unclear. The present meta-analysis is aimed to compare outcomes after percutaneous coronary intervention (PCI) with paclitaxel-coated balloons (PCB) versus sirolimus-coated balloons (SCB) for either in-stent restenosis or native de novo lesions.

Methods: The study outcomes were 1) target lesion failure (TLF), a composite of cardiac death, target vessel myocardial infarction, or target lesion revascularization, and 2) follow-up angiographic parameters including late lumen loss (LLL), diameter stenosis, and minimal lumen diameter (MLD).

View Article and Find Full Text PDF
Article Synopsis
  • Despite advancements in treatment, ST-elevation myocardial infarction (STEMI) still results in high mortality rates, leading to a greater focus on comfort-oriented care for those with poor prognoses.
  • In a study of 536 STEMI patients, 11.4% died during hospitalization, with a significant number transitioning to comfort-focused care, especially those on mechanical circulatory support.
  • Palliative care consultations were infrequent, occurring in only about 10% of cases, typically late in hospitalization, suggesting a need for earlier integration of comfort care strategies.
View Article and Find Full Text PDF
Article Synopsis
  • Augmented reality (AR) can enhance transcatheter aortic valve replacement (TAVR) procedures by providing visualization of 3D patient-specific anatomical models, potentially increasing safety and efficiency during the placement of cerebral embolic protection devices (CEP).
  • A study involving 24 patients compared those using AR guidance to a control group, finding that AR guidance significantly reduced the contrast volume needed for the procedure while not affecting the time taken for filter placement or fluoroscopy.
  • Postprocedure feedback from physicians indicated that AR guidance boosted their confidence in performing the procedure, suggesting it improved overall intervention performance despite similar procedural times.
View Article and Find Full Text PDF
Article Synopsis
  • Patients with chronic kidney disease (CKD) undergoing ultra-low contrast percutaneous coronary intervention (PCI) show minimal changes in kidney function post-procedure and have favorable one-year outcomes.
  • A study analyzed 100 CKD patients who received less than 30 mL of contrast during PCI, finding no significant difference in eGFR after the procedure and a low requirement for renal replacement therapy (RRT).
  • The research concludes that ultra-low contrast PCI is a safe option for advanced CKD patients, potentially preserving renal function and facilitating future kidney transplants.
View Article and Find Full Text PDF